965Fe0 035WO4 under applied magnetic fields above 3 6 T At zero

965Fe0.035WO4 under applied magnetic fields above 3.6 T. At zero field, this compound shows a transition into the spiral magnetic and ferroelectric phase Selleck SCH772984 at 12 K, and it becomes paraelectric

at 10.5 K with the entrance into the commensurate magnetic phase, which is the ground state at H=0. Under magnetic field above 3.6 T, however, the spiral magnetic phases with a larger FE polarization reappears below 6 K. The re-entrant magnetic/ferroelectric phase behavior is further studied by single crystal neutron scattering and the H-T phase diagram is completely resolved from neutron, dielectric constant, polarization, and magnetic measurements. (C) 2009 American Institute of Physics. [DOI: 10.1063/1.3079865]“
“Background: The current treatment of hematologic malignancies includes diverse potentially cardiotoxic chemotherapy agents, including high-dose myeloablative regimens used in autologous hematopoietic stem cell transplantation (HSCT). Many of these treatments could induce left ventricular dysfunction (LVD), and limit their efficacy. Angiotensin-converting enzime inhibitors and beta-blockers prevent LVD and prolong survival after infarction, and recent animal and pilot clinical studies suggest that they can prevent the development of chemotherapy-induced cardiac toxicity.

Methods: This is a prevention, parallel-assignment, randomized, controlled, clinical efficacy study. Ninety patients recently diagnosed find more of acute leukemia or undergoing

autologous HSCT and with normal LV ejection fraction will be randomized to enalapril and carvedilol or to the control group. Echocardiogram and a cardiac magnetic resonance imaging studies will be performed at baseline and 6-9 months after randomization. The primary efficacy endpoint is the change from baseline in LV ejection fraction. Secondary endpoints include the assessment of LV volumes and diastolic function, and the incidence of death, heart failure, or LVD.

Conclusions: The OVERCOME study will be the first clinical trial to test the preventive efficacy on LVD of combined treatment with enalapril

and carvedilol administered to patients with hematologic malignancies submitted to current treatment with intensive chemotherapy. (J Cardiac Fail 2011;17:643-648)”
“Aims and Objectives.To describe the level of knowledge, attitudes, and self-reported RepSox research buy quality of practice in pain assessment among nurses of Mainland China and explore links with current hospital pain policy and continuing education.

Background.Knowledge is necessary for skilled pain assessment among nurses. Little is currently known regarding knowledge, attitude toward, and self reported pain assessment by nurses from Mainland China.

Methods.Quantitative research and cross-sectional convenience sampling assessed nursing knowledge, attitude, and practice among 101 nurses working in high-level hospitals in Mainland China.

Results.81.2% of nurses participating in the survey were from high-level (level three) hospitals in Mainland China. 24.

Comments are closed.